nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute myeloid leukemia cell lines MOLM-17 and MOLM-18 derived from patient with advanced myelodysplastic syndromes
|
Matsuo, Yoshinobu |
|
2005 |
29 |
6 |
p. 701-710 10 p. |
artikel |
2 |
Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes
|
Giles, Francis J. |
|
2005 |
29 |
6 |
p. 649-652 4 p. |
artikel |
3 |
All-trans retinoic acid related headache in patients with acute promyelocytic leukemia: prophylaxis and treatment with acetazolamide
|
Ganguly, Siddhartha |
|
2005 |
29 |
6 |
p. 721- 1 p. |
artikel |
4 |
A morphometric approach for the evaluation of angiogenesis in acute lymphoblastic leukemia of childhood
|
Kalmanti, Lida |
|
2005 |
29 |
6 |
p. 673-677 5 p. |
artikel |
5 |
Analysis of HFE and TFR2 gene mutations in patients with acute leukemia
|
Veneri, Dino |
|
2005 |
29 |
6 |
p. 661-664 4 p. |
artikel |
6 |
Complex and simple
|
Lansky, Ephraim Philip |
|
2005 |
29 |
6 |
p. 601-602 2 p. |
artikel |
7 |
Curing acute myelogenous leukemia: Still a major challenge
|
Smith, B. Douglas |
|
2005 |
29 |
6 |
p. 607-608 2 p. |
artikel |
8 |
Engineering 3-alkyltriazenes to block bcr-abl kinase: a novel strategy for the therapy of advanced bcr-abl expressing leukemias
|
Katsoulas, Athanasia |
|
2005 |
29 |
6 |
p. 693-700 8 p. |
artikel |
9 |
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience
|
Böhm, Alexandra |
|
2005 |
29 |
6 |
p. 609-615 7 p. |
artikel |
10 |
Immune evasion strategies of pediatric precursor-B acute lymphoblastic leukemia after allogeneic bone marrow transplantation—a case study
|
Barbaric, Draga |
|
2005 |
29 |
6 |
p. 711-714 4 p. |
artikel |
11 |
Irregular nuclear shape of bone marrow plasma cells defines a multiple myeloma subgroup related to hypodiploidy and to short survival
|
Leleu, Xavier |
|
2005 |
29 |
6 |
p. 665-671 7 p. |
artikel |
12 |
Late-onset marrow aplasia due to imatinib in newly diagnosed chronic phase chronic myeloid leukaemia
|
Chng, Wee J. |
|
2005 |
29 |
6 |
p. 719-720 2 p. |
artikel |
13 |
Methylation of p15INK4b and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia
|
Shimamoto, Takashi |
|
2005 |
29 |
6 |
p. 653-659 7 p. |
artikel |
14 |
Multiple myeloma presenting initially as a solitary pleural effusion later complicated by malignant plasmacytic ascites
|
Inoue, Yoshio |
|
2005 |
29 |
6 |
p. 715-718 4 p. |
artikel |
15 |
Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia
|
Kang, Hyoung Jin |
|
2005 |
29 |
6 |
p. 617-623 7 p. |
artikel |
16 |
Pycnogenol induces differentiation and apoptosis in human promyeloid leukemia HL-60 cells
|
Huang, W.W. |
|
2005 |
29 |
6 |
p. 685-692 8 p. |
artikel |
17 |
Rituximab therapy of lymphoma is enhanced by orally administered (1→3),(1→4)-d-β-glucan
|
Modak, Shakeel |
|
2005 |
29 |
6 |
p. 679-683 5 p. |
artikel |
18 |
TEL/AML1 and immunoreceptor gene rearrangements—which comes first?
|
Zuna, Jan |
|
2005 |
29 |
6 |
p. 633-639 7 p. |
artikel |
19 |
Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes
|
Invernizzi, Rosangela |
|
2005 |
29 |
6 |
p. 641-647 7 p. |
artikel |
20 |
Therapy-related myelodysplastic syndrome in childhood: A retrospective study of 36 patients in Japan
|
Tsurusawa, M. |
|
2005 |
29 |
6 |
p. 625-632 8 p. |
artikel |
21 |
The rationale engineering of BCR/ABL blockers: an answer to STI571 acquired resistance in leukemia treatment
|
Majsterek, Ireneusz J. |
|
2005 |
29 |
6 |
p. 605-606 2 p. |
artikel |
22 |
Trying to improve clinical outcome in AML: Lessons from negative trials
|
Karp, Judith E. |
|
2005 |
29 |
6 |
p. 603-604 2 p. |
artikel |
23 |
Use of biological response modifiers to enhance the action of Rituximab
|
Taylor, Ronald P. |
|
2005 |
29 |
6 |
p. 599-600 2 p. |
artikel |